Evidence mapPaperPMID 37286509Full record

SynthesisThe Cochrane database of systematic reviews2023

Interventions for waterpipe smoking cessation.

Taghrid Asfar, Jonathan Livingstone-Banks, Kenneth D Ward, Thomas Eissenberg, Olusanya Oluwole, Zoran Bursac, Tarek Ghaddar, Wasim Maziak

Open access · greenAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in The Cochrane database of systematic reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Interventions for smokeless tobacco use cessation.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Research priorities for Article 14--demand reduction measures concerning tobacco dependence and cessation.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2013
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Taghrid AsfarSyrian Center for Tobacco Studies, Aleppo, Syrian Arab Republic.
Jonathan Livingstone-BanksNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Kenneth D WardSyrian Center for Tobacco Studies, Aleppo, Syrian Arab Republic.
Thomas EissenbergSyrian Center for Tobacco Studies, Aleppo, Syrian Arab Republic.
Olusanya OluwoleDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA.
Zoran BursacBiostatistics, Florida International University, Miami, FL, USA.
Tarek GhaddarDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA.
Wasim MaziakDepartment of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, Florida, USA.
University of Miami · USFlorida International University · USUniversity of Memphis · USUniversity of Oxford · GBVirginia Commonwealth University · US

Funding

FIC NIH HHS R01 TW010654
6 · The paper itself

Abstract

backgroundWhile cigarette smoking has declined globally, waterpipe smoking is rising, especially among youth. The impact of this rise is amplified by mounting evidence of its addictive and harmful nature. Waterpipe smoking is influenced by multiple factors, including appealing flavors, marketing, use in social settings, and misperceptions that waterpipe is less harmful or addictive than cigarettes. People who use waterpipes are interested in quitting, but are often unsuccessful at doing so on their own. Therefore, developing and testing waterpipe cessation interventions to help people quit was identified as a priority for global tobacco control efforts. 

objectivesTo evaluate the effectiveness of tobacco cessation interventions for people who smoke waterpipes. SEARCH

methodsWe searched the Cochrane Tobacco Addiction Review Group Specialized Register from database inception to 29 July 2022, using variant terms and spellings ('waterpipe' or 'narghile' or 'arghile' or 'shisha' or 'goza' or 'narkeela' or 'hookah' or 'hubble bubble'). We searched for trials, published or unpublished, in any language. SELECTION CRITERIA: We sought randomized controlled trials (RCTs), quasi-RCTs, or cluster-RCTs of any smoking cessation interventions for people who use waterpipes, of any age or gender. In order to be included, studies had to measure waterpipe abstinence at a three-month follow-up or longer. DATA COLLECTION AND ANALYSIS: We used standard Cochrane methods. Our primary outcome was abstinence from waterpipe use at least three months after baseline. We also collected data on adverse events. Individual study effects and pooled effects were summarized as risk ratios (RR) and 95% confidence intervals (95% CI), using Mantel-Haenszel random-effects models to combine studies, where appropriate. We assessed statistical heterogeneity with the I MAIN

resultsThis review included nine studies, involving 2841 participants. All studies were conducted in adults, and were carried out in Iran, Vietnam, Syria, Lebanon, Egypt, Pakistan, and the USA. Studies were conducted in several settings, including colleges/universities, community healthcare centers, tuberculosis hospitals, and cancer treatment centers, while two studies tested e-health interventions (online web-based educational intervention, text message intervention). Overall, we judged three studies to be at low risk of bias, and six studies at high risk of bias. We pooled data from five studies (1030 participants) that tested intensive face-to-face behavioral interventions compared with brief behavioral intervention (e.g. one behavioral counseling session), usual care (e.g. self-help materials), or no intervention. In our meta-analysis, we included people who used waterpipe exclusively, or with another form of tobacco. Overall, we found low-certainty evidence of a benefit of behavioral support for waterpipe abstinence (RR 3.19 95% CI 2.17 to 4.69; I

Indexed as

Smoking CessationWater Pipe SmokingAdolescentBupropionFemaleHumansRandomized Controlled Trials as TopicTobacco Use Cessation DevicesVareniclineBupropionVarenicline

Identifiers

PMID37286509
PMCPMC10245833
OpenAlexW4379768151

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.